PriceTargets.com logo

Sonic Healthcare - SKHHY Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $30.15
  • Forecasted Upside: 72.29%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$17.50 As of 06/18/2025 04:59 PM ET
▲ +0.29 (1.69%)

This chart shows the closing price for SKHHY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sonic Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SKHHY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SKHHY

Analyst Price Target is $30.15
▲ +72.29% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Sonic Healthcare in the last 3 months. The average price target is $30.15, with a high forecast of $32.20 and a low forecast of $28.10. The average price target represents a 72.29% upside from the last price of $17.50.

This chart shows the closing price for SKHHY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 2 investment analysts is to moderate buy stock in Sonic Healthcare. This rating has held steady since March 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/18/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/17/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/4/2025The Goldman Sachs GroupUpgradeStrong-Buy
4/3/2025The Goldman Sachs GroupSet TargetNeutral ➝ Buy$32.20
3/19/2025Morgan StanleySet Target$28.10
8/26/2024Royal Bank Of CanadaUpgradeHold
3/6/2023CitigroupUpgradeNeutral ➝ Buy
9/1/2022Jefferies Financial GroupUpgradeHold ➝ Buy
8/28/2022The Goldman Sachs GroupDowngradeNeutral ➝ Sell
2/21/2022Jefferies Financial GroupDowngradeBuy ➝ Hold
1/13/2022CLSADowngradeOutperform ➝ Underperform
10/4/2021Jefferies Financial GroupUpgradeHold ➝ Buy$45.75
6/22/2021CitigroupDowngradeBuy ➝ Neutral
4/8/2021Jefferies Financial GroupDowngradeBuy ➝ Hold
2/26/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral
2/18/2021Jefferies Financial GroupUpgradeHold ➝ Buy
(Data available from 6/18/2020 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/20/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/19/2025
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/18/2025
  • 1 very positive mentions
  • 4 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2025
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
4/19/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/19/2025
  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/18/2025

Current Sentiment

  • 2 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Sonic Healthcare logo
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
Read More

Today's Range

Now: $17.50
Low: $16.44
High: $18.40

50 Day Range

MA: $16.87
Low: $15.47
High: $17.70

52 Week Range

Now: $17.50
Low: $14.47
High: $20.59

Volume

182,518 shs

Average Volume

51,656 shs

Market Capitalization

$8.41 billion

P/E Ratio

N/A

Dividend Yield

2.84%

Beta

1.03

Frequently Asked Questions

What sell-side analysts currently cover shares of Sonic Healthcare?

The following sell-side analysts have issued reports on Sonic Healthcare in the last twelve months: Morgan Stanley, Royal Bank Of Canada, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for SKHHY.

What is the current price target for Sonic Healthcare?

0 Wall Street analysts have set twelve-month price targets for Sonic Healthcare in the last year. Their average twelve-month price target is $30.15, suggesting a possible upside of 72.3%. The Goldman Sachs Group, Inc. has the highest price target set, predicting SKHHY will reach $32.20 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $28.10 for Sonic Healthcare in the next year.
View the latest price targets for SKHHY.

What is the current consensus analyst rating for Sonic Healthcare?

Sonic Healthcare currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SKHHY.

What other companies compete with Sonic Healthcare?

Other companies that are similar to Sonic Healthcare include Premium Brands, Sonic Healthcare, Daikin Industries,Ltd., Swire Pacific and Sun Hung Kai Properties. Learn More about companies similar to Sonic Healthcare.

How do I contact Sonic Healthcare's investor relations team?

Sonic Healthcare's physical mailing address is Macquarie Park, Macquarie, New South Wales 2113. The company's listed phone number is (129) 855-5444. The official website for Sonic Healthcare is www.sonichealthcare.com. Learn More about contacing Sonic Healthcare investor relations.